Medtronic Navigation, Inc. appears in FDA device enforcement records as the recalling firm for four related Class II actions, all tied to event 99895 and all reported on 28 October 2026. The products named are Medtronic NDI Passive Spheres in three tray configurations and a Medtronic Biopsy Needle Kit. The stated reason across the records is variation in the reflective material of sterile passive spheres and biopsy needle kits, which may affect the ability of the navigation system to detect and track the spheres. A Swiss field safety notice published by the manufacturer describes the same action as a recall of specific lots of Northern Digital Inc (NDI) Passive Sphere and Medtronic Biopsy Needle Kits. [1][2][3][4][10]
Products named in the enforcement records
The four FDA enforcement entries identify distinct product configurations. The Biopsy Needle Kit carries REF 9733068 and is described as passive, sterile EO and prescription-only. The passive spheres appear as REF 8801075 in a 5-per-tray, 12-pack format; REF 8801074 in a 4-per-tray, 12-pack format; and REF 8801071 in a 1-per-tray, 12-pack format. Each entry lists UDI and lot information in its code field, and each is classified Class II with status Ongoing. [1][2][3][4]
The manufacturer's Swiss field safety notice, dated September 2026 and referenced FA00002, names the NDI Passive Sphere models 8801074 and 8801075 for specific lots and the Medtronic Biopsy Needle Kit model 9733068 for specific lots. It states that Medtronic is recalling specific lots of Northern Digital Inc (NDI) Passive Sphere and Medtronic Biopsy Needle Kits because of variability in the sphere reflective coating. The notice is issued by Medtronic (Schweiz) AG and lists an EU manufacturer single registration number. [10]
Scope, quantities and distribution
The enforcement records give product quantities per entry: 3,746 units for the Biopsy Needle Kit, 476,256 units for the 5-per-tray passive spheres, 14,210 units for the 1-per-tray passive spheres and 83,594 units for the 4-per-tray passive spheres. These are the quantities stated in each individual record, not a combined total. [1][2][3][4]
Distribution described in the records covers the United States across a long list of states plus Puerto Rico, with additional markets listed as Canary Islands, Iceland, Northern Ireland, Martinique, China, Taiwan and Hong Kong in some entries. The records state that the action was voluntary and firm initiated, with initial firm notification by letter. Recall initiation is dated 31 August 2026, center classification 16 October 2026 and report date 28 October 2026. [1][2][3][4]
Related FDA database entries
Separate FDA recall database pages carry the titles Class 2 Device Recall Medtronic Biopsy Needle Kit and Class 2 Device Recall Medtronic NDI Passive Spheres, matching the product families in the enforcement entries. A MAUDE adverse event report page is titled for MEDTRONIC NAVIGATION, INC. Passive Biopsy Needle, with the device category neurological stereotaxic instrument. These pages establish the existence of the records and their titles; the retrieved text does not include further detail on the event narrative. [5][6][7][8][9]
What the records do and do not establish
The records establish the recalling firm name, the product names and references, the stated reason for recall, classification, status, quantities and distribution. They do not establish corporate ownership, headquarters location, manufacturing sites beyond the address listed in the filings, customer lists, clinical performance or the outcome of the recall. The filing address in Lafayette, Colorado appears in the enforcement records and is not treated here as a headquarters. [1][2][3][4]
The linked-record collection retrieved for this profile contains no records by pathway and no decision counts, so no portfolio-level or safety-performance statement can be drawn from it. The four enforcement entries and the manufacturer notice describe one recall event and its product scope only. [1][2][3][4][10]




